42291-0458 Ondansetron - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

42291-0458

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 42291-0458-30

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (42291-458-30)

Effective Date: May 15, 2025

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use